In the context of the search for biomarkers that could help in the prediction of treatment effectiveness, which represents a particularly relevant issue for MDD and especially for TRD, BDNF has also been investigated for its potential to predict the outcome of pharmacological treatment when measured before the therapy or in its early phases. The gene discussed is BDNF; the disease is treatment resistant depression.